— Know what they know.
Not Investment Advice

LXEO NASDAQ

Lexeo Therapeutics, Inc. Common Stock
1W: -4.9% 1M: -17.4% 3M: -16.9% YTD: -45.6% 1Y: +48.2%
$5.11
-0.12 (-2.29%)
After Hours: $4.93 (-0.18, -3.42%)
Weekly Expected Move ±8.7%
$4 $5 $5 $6 $6
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 28 · $401.2M mcap · 48M float · 1.89% daily turnover · Short 78% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-88M
Net Income
+19.9% YoY
$-98M
Free Cash Flow
-11.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-48.1%
ROA-42.1%
ROIC-40.3%

Valuation

P/E-4.7
P/B1.8
EV/EBITDA-4.7

Leverage

Debt/Equity0.03
Current Ratio11.21
Interest Cov.-727.9x

Quality Scores

Piotroski F3/9
Altman Z10.38
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms